Context Therapeutics Inc.
CNTX
$0.52
$0.023.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 42.99M | 54.53M | 66.00M | 76.94M | 83.52M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.63M | 3.79M | 2.16M | 1.92M | 3.23M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 200.00K | 200.00K | 200.00K | 200.00K | 200.00K |
| Total Current Assets | 45.82M | 58.52M | 68.35M | 79.06M | 86.95M |
|
|
|||||
| Total Current Assets | 45.82M | 58.52M | 68.35M | 79.06M | 86.95M |
| Net Property, Plant & Equipment | 315.30K | 342.30K | 140.10K | 172.30K | 203.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 46.13M | 58.86M | 68.49M | 79.23M | 87.15M |
|
|
|||||
| Total Accounts Payable | 3.29M | 2.47M | 2.53M | 2.72M | 2.40M |
| Total Accrued Expenses | 4.41M | 2.99M | 5.34M | 3.16M | 2.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 167.50K | 160.10K | 112.10K | 119.00K | 115.00K |
| Total Finance Division Other Current Liabilities | 21.40K | 921.10K | 39.00K | 34.60K | 37.70K |
| Total Other Current Liabilities | 21.40K | 921.10K | 39.00K | 34.60K | 37.70K |
| Total Current Liabilities | 7.88M | 6.53M | 8.02M | 6.04M | 4.56M |
|
|
|||||
| Total Current Liabilities | 7.88M | 6.53M | 8.02M | 6.04M | 4.56M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 77.50K | 122.40K | -- | 21.20K | 52.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.96M | 6.66M | 8.02M | 6.06M | 4.61M |
|
|
|||||
| Common Stock & APIC | 192.31M | 191.79M | 191.38M | 191.05M | 190.73M |
| Retained Earnings | -154.14M | -139.58M | -130.90M | -117.88M | -108.18M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 38.17M | 52.20M | 60.47M | 73.17M | 82.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 38.17M | 52.20M | 60.47M | 73.17M | 82.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 38.17M | 52.20M | 60.47M | 73.17M | 82.54M |
|
|
|||||